MX9802486A - Helicobacter pylori protein. - Google Patents

Helicobacter pylori protein.

Info

Publication number
MX9802486A
MX9802486A MX9802486A MX9802486A MX9802486A MX 9802486 A MX9802486 A MX 9802486A MX 9802486 A MX9802486 A MX 9802486A MX 9802486 A MX9802486 A MX 9802486A MX 9802486 A MX9802486 A MX 9802486A
Authority
MX
Mexico
Prior art keywords
helicobacter pylori
pylori protein
pylori
antigenic protein
protein
Prior art date
Application number
MX9802486A
Other languages
Spanish (es)
Other versions
MXPA98002486A (en
Inventor
Bow Ho
Original Assignee
Cortecs Internat Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cortecs Internat Ltd filed Critical Cortecs Internat Ltd
Publication of MX9802486A publication Critical patent/MX9802486A/en
Publication of MXPA98002486A publication Critical patent/MXPA98002486A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K2039/106Vibrio; Campylobacter; Not used, see subgroups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The present invention provides a novel antigenic protein obtainable from the coccoid form of H. pylori. The use of the antigenic protein in methods of detecting H. pylori, as well as in the preparation of vaccines, is also disclosed. A method of culturing the coccoid form of H. pylori is also provided.
MXPA/A/1998/002486A 1995-09-29 1998-03-30 Helicobacter pyl protein MXPA98002486A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9519865.1A GB9519865D0 (en) 1995-09-29 1995-09-29 Protein
GB9519865.1 1995-09-29

Publications (2)

Publication Number Publication Date
MX9802486A true MX9802486A (en) 1998-10-31
MXPA98002486A MXPA98002486A (en) 1999-01-11

Family

ID=

Also Published As

Publication number Publication date
AU7137896A (en) 1997-04-28
CA2233328A1 (en) 1997-04-10
KR19990063833A (en) 1999-07-26
CN1201464A (en) 1998-12-09
EP0859788A1 (en) 1998-08-26
BR9610953A (en) 1999-12-21
NO981407L (en) 1998-05-28
GB9519865D0 (en) 1995-11-29
ZA968185B (en) 1998-03-27
NO981407D0 (en) 1998-03-27
WO1997012910A1 (en) 1997-04-10
JP2000500123A (en) 2000-01-11

Similar Documents

Publication Publication Date Title
HU9603155D0 (en) Papillomavirus vaccines
ZA837603B (en) Immunogenic protein or peptide complex,method of producing said complex and the use thereof as an immune stimulant and as a vaccine
MY133780A (en) Vaccine composition
IL127661A0 (en) Induction of CTLs specific for natural antigens by cross-priming immunization
AU7237391A (en) Carrier-bound recombinant protein, process for producing it and its use as an immunogen and vaccine
AU6892991A (en) A method for the stepwise, controlled synthesis of chemical species, particularly peptides, coupled products obtained by the method and the use of these coupled products, e.g. as vaccines
AU4208497A (en) Helicobacter pylori live vaccine
AU1459792A (en) Basic structural immunogenic polypeptides having epitopes for hcv, antibodies, polynucleotide sequences, vaccines and methods
WO1997011669A3 (en) MHC-class II restricted melanoma antigens and their use in therapeutic methods
AU1681095A (en) Hydrophilic signal oligopeptides and methods of therapeutic use
NL300336I1 (en) Mumps vaccine containing a jeryl-lynn virus strain
MX9802486A (en) Helicobacter pylori protein.
MX9702432A (en) Methods for producing enhanced antigenic helicobacter sp. and vaccines comprising same.
MX9702431A (en) Methods for producing enhanced antigenic enteric bacteria and vaccines comprising same.
ZA873922B (en) Method of preparation and use for feline leukemia virus antigens
DE69615537D1 (en) Helicobacter pylori antigen
EP0726463A3 (en) Method for serotyping using type-specific antigens
WO1990015132A3 (en) Cloned treponema hyodysenteriae endoflagellar antigen
EP0563288A4 (en) Immunopotentiation of vaccines, particularly swine pleuropneumonia vaccines
MX9701267A (en) Glutamate receptor.